Admission blood glucose is an independent predictive factor for hospital mortality in polytraumatised patients

Janett Kreutziger1, Volker Wenzel, Andrea Kurz

  • 1Department of Anaesthesiology and Critical Care Medicine, Innsbruck Medical University, Innsbruck, Austria. janett.kreutziger@uki.at

Intensive Care Medicine
|February 25, 2009
PubMed

Insights

Admission blood glucose is a key predictor of hospital mortality in polytraumatised patients. This study developed a more accurate mortality prediction model using blood glucose levels for trauma patients.

Area of Science:

  • Trauma care
  • Clinical outcomes research
  • Medical prediction modeling

Background:

  • Polytrauma patients face high hospital mortality rates.
  • Accurate prediction of outcomes is crucial for effective trauma management.
  • Existing prediction models may lack precision for this patient group.

Purpose of the Study:

  • To investigate the association between admission blood glucose and hospital mortality in polytraumatised patients.
  • To develop and validate a novel outcome prediction model for polytrauma patients.
  • To enhance the accuracy of mortality prediction in severe trauma cases.

Main Methods:

  • Retrospective analysis of adult polytraumatised patients (ISS > or = 17) admitted between 2002-2004.
  • Inclusion of patients with more than one severely injured organ system.
  • Multiple regression analysis to identify independent predictors of mortality.

Main Results:

  • Hyperglycaemia identified as an independent predictor of hospital mortality (P < 0.0001).
  • A mortality prediction model incorporating admission blood glucose demonstrated superior performance (AUC 0.924).
  • The new model showed significant improvement over existing prediction tools (P < 0.0001).

Conclusions:

  • Admission blood glucose is a significant independent predictor of hospital mortality in polytraumatised patients.
  • A reliable blood glucose-based mortality prediction model for polytrauma patients was successfully established.
  • Further prospective studies are warranted to validate these findings and improve trauma outcome prediction.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...